Experience of extracorporeal membrane oxygenation as a bridge to lung transplantation in France Marion Lafarge, MD, Pierre Mordant, MD, Gabriel Thabut, MD, PhD, Laurent Brouchet, MD, Pierre-Emmanuel Falcoz, MD, Alain Haloun, MD, Françoise Le Pimpec-Barthes, MD, PhD, Jean-Michel Maury, MD, Martine Reynaud-Gaubert, MD, PhD, Christelle Saint-Raymond, MD, Edouard Sage, MD, Marc Stern, MD, Pascal Thomas, MD, PhD, Yves Castier, MD, PhD, Richard Dorent, MD, Hervé Mal, MD, PhD The Journal of Heart and Lung Transplantation Volume 32, Issue 9, Pages 905-913 (September 2013) DOI: 10.1016/j.healun.2013.06.009 Copyright © 2013 International Society for Heart and Lung Transplantation Terms and Conditions
Figure 1 Outcomes of 36 patients who received extracorporeal membrane oxygenation (ECMO) as a bridge to lung transplantation (LTx). CPB, cardiopulmonary bypass; VA, venoarterial; VV, venovenous. The Journal of Heart and Lung Transplantation 2013 32, 905-913DOI: (10.1016/j.healun.2013.06.009) Copyright © 2013 International Society for Heart and Lung Transplantation Terms and Conditions
Figure 2 Cumulative incidence of lung transplantation (LTx) and death over time for the 36 patients in the study. ECMO, extracorporeal membrane oxygenation. The Journal of Heart and Lung Transplantation 2013 32, 905-913DOI: (10.1016/j.healun.2013.06.009) Copyright © 2013 International Society for Heart and Lung Transplantation Terms and Conditions
Figure 3 Survival from extracorporeal membrane oxygenation (ECMO) initiation for the 36 patients in the study by underlying disease. CF, cystic fibrosis. The Journal of Heart and Lung Transplantation 2013 32, 905-913DOI: (10.1016/j.healun.2013.06.009) Copyright © 2013 International Society for Heart and Lung Transplantation Terms and Conditions